Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 20, Issue 2, 2013, Pages 118-123

  Skog, Oskar ^a   Korsgren, Stella ^a   Melhus, Åsa ^b   Korsgren, Olle ^a,c  

^a Department of Immunology Genetics and Pathology ^*  (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Autoimmunity; Cause; Innate immunity; T cells; Type 1 diabetes

Indexed keywords

HLA ANTIGEN; INSULIN;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL FEATURE; DISEASE COURSE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; LIPOTOXICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PANCREAS; PANCREAS ISLET; PANCREAS ISLET CELL; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; IMMUNOTHERAPY; INFLAMMATION; PANCREAS, EXOCRINE; T-LYMPHOCYTES;

EID: 84874946657     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32835edb89     Document Type: Review

References (40)

1. Coppieters KT, Dotta F, Amirian N, et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 2012; 209:51-60.
2. Bulek AM, Cole DK, Skowera A, et al. Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes. Nat Immunol 2012; 13:283-289.
3. Abreu JR, Martina S, Verrijn Stuart AA, et al. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clin Exp Immunol 2012; 170:57-65.
4. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, et al. A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem 2012; 287:1168-1177.
5. In't Veld P. Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 2011; 3:131-138.
6. Roep BO, Atkinson M, von Herrath M. Satisfaction (not) guaranteed: reevaluating the use of animal models of type 1 diabetes. Nat Rev Immunol 2004; 4:989-997.
7. Sarkar SA, Lee CE, Victorino F, et al. Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes 2012; 61:436-446.
8. Gaglia JL, Guimaraes AR, Harisinghani M, et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest 2011; 121:442-445.
9. Williams AJ, Thrower SL, Sequeiros IM, et al. Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes. J Clin Endocrinol Metab 2012; 97:E2109-E2113.
10. Creutzfeldt W, Gleichmann D, Otto J, et al. Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion 2005; 72:71-75.
11. Sato M, Yamamoto K, Mayama H, Yamashiro Y. Exocrine pancreatic function in diabetic children. J Pediatr Gastroenterol Nutr 1984; 3:415-420.
12. Hardt PD, Ewald N, Brockling K, et al. Distinct autoantibodies against exocrine pancreatic antigens in European patients with type 1 diabetes mellitus and nonalcoholic chronic pancreatitis. Jop 2008; 9:683-689.
13. Panicot L, Mas E, Thivolet C, Lombardo D. Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. Diabetes 1999; 48:2316-2323.
14. Taniguchi T, Tanaka J, Seko S, et al. Association of rapid-onset type 1 diabetes and clinical acute pancreatitis positive for autoantibodies to the exocrine pancreas. Diabetes Care 2001; 24:2156-2157.
15. Andralojc K, Srinivas M, Brom M, et al. Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis. Diabetologia 2012; 55:1247-1257.
16. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14:619-633.
17. Butler AE, Galasso R, Meier JJ, et al. Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 2007; 50:2323-2331.
18. Greenbaum CJ, Beam CA, Boulware D, et al. Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes 2012; 61:2066-2073.
19. Dabelea D, Mayer-Davis EJ, Andrews JS, et al. Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 2012.
20. Ylipaasto P, Klingel K, Lindberg AM, et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004; 47:225-239.
21. Tracy S, Drescher KM, Chapman NM. Enteroviruses and type 1 diabetes. Diabetes Metab Res Rev 2011; 27:820-823.
22. Staeva-Vieira T, Peakman M, von Herrath M. Translational mini-review series on type 1 diabetes: immune-based therapeutic approaches for type 1 diabetes. Clin Exp Immunol 2007; 148:17-31.
23. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009; 361:2143-2152.
24. Keymeulen B, Walter M, Mathieu C, et al. Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia 2010; 53:614-623.
25. Herold KC, Gitelman S, Greenbaum C, et al. Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years. Clin Immunol 2009; 132:166-173.
26. Lecompte PM. Insulitis in early juvenile diabetes. AMA Arch Pathol 1958; 66:450-457.
27. Meier JJ, Bhushan A, Butler AE, et al. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 2005; 48:2221-2228.
28. Patterson CC, Dahlquist GG, Gyurus E, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 20 a multicentre prospective registration study. Lancet 2009; 373:2027-2033.
29. Berhan Y, Waernbaum I, Lind T, et al. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 2011; 60:577-581.
30. Concannon P, Chen WM, Julier C, et al. Genome-wide scan for linkage to type 1 diabetes in 2496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes 2009; 58:1018-1022.
31. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009; 360:1646-1654.
32. Korsgren S, Molin Y, Salmela K, et al. On the etiology of type 1 diabetes: a new animal model signifying a decisive role for bacteria eliciting an adverse innate immunity response. Am J Pathol 2012; 181:1735-1748.
33. Flores C, Maguilnik I, Hadlich E, Goldani LZ. Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital. J Gastroenterol Hepatol 2003; 18:333-336.
34. Negm AA, Schott A, Vonberg RP, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 2010; 72:284-291.
35. Schmid SW, Uhl W, Friess H, et al. The role of infection in acute pancreatitis. Gut 1999; 45:311-316.
36. Scharp DW, Lacy PE, McLear M, et al. The bioburden of 590 consecutive human pancreata for islet transplant research. Transplant Proc 1992; 24: 974-975.
37. Kin T, Rosichuk S, Shapiro AM, Lakey JR. Detection of microbial contamination during human islet isolation. Cell Transplant 2007; 16: 9-13.
38. Bucher P, Oberholzer J, Bosco D, et al. Microbial surveillance during human pancreatic islet isolation. Transplant Int 2005; 18:584-589.
39. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314:1360-1368.
40. Taniguchi T, Okazaki K, Okamoto M, et al. High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in type 1 diabetes: concept of autoimmune exocrinopathy and endocrinopathy of the pancreas. Pancreas 2003; 27:26-30.